These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released via email or RSS.
Sep 8, 2015
BioDelivery Sciences Secures Exclusive Preferred Formulary Status for BUNAVAIL® with Tennessee Medicaid (TennCare)
As of October 1, all patients presenting a buprenorphine/naloxone prescription will receive BUNAVAIL
Aug 13, 2015
BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS® (fentanyl buccal soluble film) CII
Approval of new formulation expected to allow ONSOLIS to return to U.S. market in 2016